Transduction and utility of the granulocyte-macrophage colony- stimulating factor gene into monocytes and dendritic cells by adeno- associated virus

Journal of Interferon and Cytokine Research

Volumn 20, Issue 1, 2000, Pages 21-30

  Liu, Yong ^a   Santin, Alessandro D ^a   Mane, Michael ^a   Chiriva Internati, Maurizio ^a   Parham, Groesbeck P ^a   Ravaggi, Antonella ^a   Hermonat, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; RNA; TUMOR NECROSIS FACTOR ALPHA;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL PROLIFERATION; CLONING VECTOR; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GENE AMPLIFICATION; GENE TARGETING; GENETIC MANIPULATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MONOCYTE; MUTATION; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; ANTIGENS, CD; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DENDRITIC CELLS; DEPENDOVIRUS; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULINS; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; RNA, MESSENGER; TRANSFECTION; VIRUS INTEGRATION;

ADENO-ASSOCIATED VIRUS;

EID: 0033980793     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000312702     Document Type: Article

References (53)

1. STEINMAN, R.A. (1991). The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-296.
2. SALLUSTO, F., and LANZAVECCHIA, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118.
3. ROMANI, N., GRUNER, S., BRANG, D., KAMPGEN, E., LENZ, A., TROCKENBACHER, B., KONWALINKA, G., FRITSCH, P.O., STEINMAN, R.M., and SCHULER, G. (1994). Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83-93.
4. YOUNG, J.W., and INABA, K. (1996). Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183, 7-11.
5. KIM, C.J., PREVETTE, T., CORMIER, J., OVERWIJK, W., RODEN, M., RESTIFO, N.P., ROSENBERG, S.A., and MARINCOLA, F.M. (1997). Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro. J. Immunother. 20, 276-286.
6. SPECHT, J.M., WANG, G., DO, M.T., LAM, J.S., ROYAL, R.E., REEVES, M.E., ROSENBERG, S.A., and HWU, P. (1997). Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 186, 1213-1221.
7. REEVES, M.E., ROYAL, R.E., LAM, J.S., ROSENBERG, S.A., and HWU, P. (1996). Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56, 5672-5677.
8. SMITH, C.A., WOODRUFF, L.S., KITCHINGMAN, G.R., and ROONEY, C.M. (1996). Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J. Virol. 70, 6733-6740.
9. BEI, R., GUPTILL, V., MASUELLI, L., KASHMIRI, S.V., MURARO, R., FRATI, L., SCHLOM, J., and KANTOR, J. (1998). The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice. J. Immunother. 21, 159-169.
10. NAIR, S., ZHOU, X., HUANG, L., and ROUSE, B.T. (1992). Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines. J. Immunol. Methods 152, 237-243.
11. FAWELL, S., SEERY, J., DAIKH, Y., MOORE, C., CHEN, L.L., PEPINSKY, B., and BARSOUM, J. (1994). Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91, 664-668.
12. GRAZIADEI, L., BURFEIND, P., and Bar-Sagi, D. (1991). Introduction of unlabeled proteins into living cells by electroporation and isolation of viable protein-loaded cells using dextran-fluorescein isothiocyanate as a marker for protein uptake. Anal. Biochem. 194, 198-203.
13. KIM, D., LEE, Y.J., RAUSCH, C.M., and BORRELLI, M.J. (1991). Electroporation of extraneous proteins into CHO cells: increased efficacy by utilizing centrifugal force and microsecond electrical pulses. Exp. Cell Res. 197, 207-212.
14. SUGAWA, H., IMAMOTO, N., WATAYA-KANEDA, M., and UCHIDA, T. (1985). Foreign protein can be carried into the nucleus of mammalian cell by conjugation with nucleoplasmin. Exp. Cell Res. 159, 419-429.
15. ORTIZ, D., BALDWIN, M.M., and LUCAS, J.J. (1987). Transient correction of genetic defects in cultures of animal cells by injection of functional proteins. Mol. Cell. Biol. 7, 3012-3017.
16. KEDAR, E., PALGI, O., GOLOD, G., BABAI, I., and BARENHOLZ, Y. (1997). Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in mice. J. Immunother. 20, 180-193.
17. CONLON, P.J., TYLER, S., GRABSTEIN, K.H., and MORRISSEY, P. (1989). Interleukin-4 (B-cell stimulatory factor-1) augments the in vivo generation of cytotoxic cells in immunosuppressed animals. Biotechnol. Ther. 1, 31-41.
18. HERMONAT, P.L., LABOW, M.A., WRIGHT, R., BERNS, K.I., and MUZYCZKA, N. (1984). Genetics of adeno-associated virus: isolation and preliminary characterization of mutants in adeno-associated virus type 2. J. Virol. 51, 329-339.
19. LABOW, M.A., HERMONAT, P.L., and BERNS, K.I. (1986). Positive and negative autoregulation of the adeno-associated virus type 2 genome. J. Virol. 60, 251-258.
20. HERMONAT, P.L., and MUZYCZKA, N. (1984). Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. USA 81, 6466-6470.
21. LAFACE, D., HERMONAT, P.L., WAKELAND, E.K., and PECK, A.B. (1988). Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector. Virology 162, 483-486.
22. ZHOU, S.Z., BROXMEYER, H.E., COOPER, S., HARRINGTON, M.A., and SRIVASTAVA, A. (1993). Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exp. Hematol. 21, 928-933.
23. PODSAKOFF, G., WONG, K.K., Jr., and CHATTERJEE, S. (1994). Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol. 74, 5656-5666.
24. CHIORINI, J.A., WENDTNER, C.M., URCELAY, E., SAFER, B., HALLEK, M., and KOTIN, R.M. (1995). High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene Ther. 6, 1531-1541.
25. SAMULSKI, R.J., BERNS, K.I., TAN, M., and MUZYCZKA, N. (1982). Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA 79, 2077-2081.
26. RUSSELL, D.W., MILLER, A.D., and ALEXANDER, I.E. (1994). Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91 8915-8919.
27. ZOLOTUKHIN, S., POTTER, M., HAUSWIRTH, W.W., GUY, J., and MUZYCZKA, N. (1996). A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70, 4646-5464.
28. HERMONAT, P.L., QUIRK, J.G., BISHOP, B.M., and HAN, L. (1997). Packaging capacity of adeno-associated virus and the potential for wild type-plus AAV gene therapy vectors. FEBS Lett. 407, 78-84.
29. HIRT, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-370.
30. SOUTHERN, E.M. (1975). Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98, 503-517.
31. HERMONAT, P.L., HAN, L., WENDEL, P.J., QUIRK, J.G., STERN, S., LOWERY, C.L., and RECHTIN, T.M. (1997). Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. Virus Genes 14, 13-17.
32. PISA, P., HALAPI, E., PISA, E.K., GERDIN, E., HISING, C., BUCHT, A., GERDIN, B., and KIESSLING, R. (1992). Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. Natl. Acad. Sci. USA 89, 7708-7712.
33. BATZER, M.A., GUDI, V.A., MENA, J.C., FOLTZ, D.W., HERRERA, R.J., and DEININGER, P.L. (1991). Amplification dynamics of human-specific (HS) Alu family members. Nucleic Acids Res. 19, 3619-3623.
34. SOUTHERN, P.J., and BERG, P. (1982). Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1, 327-340.
35. SANTIN, A.D., HERMONAT, P.L., RAVAGGI, A., CHIRIVA-INTERNATI, M., HISERODT, J.C., PECORELLI, S., and PARHAM, G.P. (1999). Kinetics of expression of surface antigens during the differentiation of human dendritic cells versus macrophages from monocytes in vitro. Immunobiology 200, 187-204.
36. WU, P., PHILLIPS, M.I., BUI, J., and TERWILLIGER, E.F. (1998). Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J. Virol. 72, 5919-5927.
37. ALEXANDER, I.E., RUSSELL, D.W., SPENCE, A.M., and MILLER, A.D. (1996). Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7, 841-850.
38. RUSSELL, D.W., ALEXANDER, I.E., and MILLER, A.D. (1995). DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 92, 5719-5723.
39. HALBERT, C.L., ALEXANDER, I.E., WOLGAMOT, G.M., and MILLER, A.E. (1995). Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J. Virol. 69, 1473-1479.
40. LARDON, F., SNOECK, H.W., BERNEMAN, Z.N., VAN TENDELOO, V.F., NIJS, G., LENJOU, M., HENCKAERTS, E., BOECKXTAENS, C.J., VANDENABEELE, P., KESTENS, L.L., VAN BOCKSTAELE, D.R., and VANHAM G.L. (1997). Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1. Immunology 91, 553-559.
41. MALIK, P., McQUISTON, S.A., YU, X.J., PEPPER, K.A., KRALL, W.J., PODASKOFF, G.M., KURTZMAN, G.J., and KOHN, D.B. (1997). Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J. Virol. 71, 1776-1783.
42. WU, P., PHILLIPS, M.I., BUI, J., and TERWILLIGER, E.F. (1998). Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J. Virol. 72, 5919-5926.
43. HOGGAN, M.D., THOMAS, G., and JOHNSON, F.B. (1972). Continuous carriage of adenovirus-associated virus genome in cell culture in the absence of helper adenovirus. In: Proceedings of the Fourth Lepetite Colloquium. Cocoyac, Mexico. Amsterdam: North-Holland, pp. 243-249.
44. CHEUNG, A.K.M., HOGGAN, M.D., HAUSWIRTH, W.W., and BERNS, K.I. (1980). Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J. Virol. 33, 739-748.
45. LAUGHLIN, C.A., CARDELLICHIO, C.B., and COON, H.C. (1986). Latent infection of KB cells with adeno-associated virus type 2. J. Virol. 60, 515-524.
46. CLARK, K.R., SFERRA, T.J., and JOHNSON, P.R. (1997). Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8, 659-669.
47. XIAO, X., LI, J., and SAMULSKI, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098-8108.
48. MONAHAN, P.E., SAMULSKI, R.J., TAZELAAR, J., XIAO, X., NICHOLS, T.C., BELLINGER, D.A., READ, M.S., and WALSH, C.E. (1998). Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. 5, 40-49.
49. POOK, M.A., WOODCOCK, V., TASSABEHJI, M., CAMPBELL, R.D., SUMMERS, C.W., TAYLOR, M., and STRACHAN, T. (1991). Characterization of an expressible nonclassical class I HLA gene. Hum. Immunol. 32, 102-109.
50. 2-microglobulin mutations. HLA class I antigen loss, and tumor progression in melanoma. J. Clin. Invest. 101, 2720-2729.
51. 2-microglobulin gene mutations in human melanoma cells: molecular characterization and implications for immune surveillance. Melanoma Res. 7 (Suppl. 2):S67.
52. TIBERGHIEN, P., REYNOLDS, C.W., KELLER, J., SPENCE, S., DESCHASEAUX, M., CERTOUX, J.M., CONTASSOT, E., MURPHY, W.J., LYONS, R., CHIANG, Y., et al. (1994). Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84, 1333-1341.
53. YOUNG, J.W., and INABA, K. (1996). Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183, 7-13.